BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 8118325)

  • 1. AgNORs in ductal breast cancer: correlation with ploidy and S-phase fraction by DNA flow cytometry.
    Borgiani L; Cogorno P; Oliviero J; Toso F; Gambini G; Tunesi G; Canepa M
    Eur J Histochem; 1994; 38(2):171-6. PubMed ID: 7524814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle analysis of 932 flow cytometric DNA histograms of fresh frozen breast carcinoma material. Correlations between flow cytometric, clinical, and pathologic variables. MMMCP Collaborative Group. Multicenter Morphometric Mammary Carcinoma Project Collaborative Group.
    Bergers E; van Diest PJ; Baak JP
    Cancer; 1996 Jun; 77(11):2258-66. PubMed ID: 8635093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of the urokinase-type plasminogen activator, and its inhibitors and receptor in breast cancer patients.
    Borstnar S; Vrhovec I; Svetic B; Cufer T
    Clin Breast Cancer; 2002 Jun; 3(2):138-46. PubMed ID: 12123538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Flow cytometry detected S-phase fraction and ploidy as prognostic parameters in primary, node-negative breast cancer].
    Winter K; Eidtmann H; Jonat W
    Geburtshilfe Frauenheilkd; 1994 May; 54(5):291-4. PubMed ID: 8050690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [DNA flow cytometric analysis in primary breast cancer. S-phase and ploidy status as prognostic factors and their correlation to tumor-associated proteolytic factors].
    Harbeck N; Schüren E; Yamamoto N; Pache L; Schmitt M; Jänicke F; Dettmar P; Höfler H; Graeff H
    Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():303-4. PubMed ID: 8118325
    [No Abstract]   [Full Text] [Related]  

  • 6. [DNA ploidy pattern, S-phase fraction as a prognostic factor of breast cancers].
    Kimijima I; Katagata N; Tsuchiya A; Takenoshita S
    Nihon Rinsho; 2000 Apr; 58 Suppl():401-6. PubMed ID: 11026024
    [No Abstract]   [Full Text] [Related]  

  • 7. [Flow cytometric analysis of DNA ploidy pattern in breast cancer: malignant potential and prognostic implication].
    Hara S; Tomita M
    Nihon Rinsho; 1992 Oct; 50(10):2444-9. PubMed ID: 1447815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric (DNA content and S-phase fraction) analysis of breast cancer.
    Batsakis JG; Sneige N; el-Naggar AK
    Cancer; 1993 Mar; 71(6 Suppl):2151-3. PubMed ID: 8443764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [tPA, uPA, PAI-1 as prognostic factors of breast cancers].
    Shiba E; Kim SJ
    Nihon Rinsho; 2000 Apr; 58 Suppl():429-34. PubMed ID: 11026029
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical relevance of prognostic factors in axillary node-negative breast cancer.
    Thomssen C; Jänicke F; Harbeck N
    Onkologie; 2003 Oct; 26(5):438-45. PubMed ID: 14605459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA and cell cycle analysis as prognostic indicators in breast tumors revisited.
    Bagwell CB; Clark GM; Spyratos F; Chassevent A; Bendahl PO; Stål O; Killander D; Jourdan ML; Romain S; Hunsberger B; Wright S; Baldetorp B
    Clin Lab Med; 2001 Dec; 21(4):875-95, x. PubMed ID: 11770293
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.